U.S. Hospitality Stock News

Ryan Specialty Holdings (RYAN) has been in focus after its latest quarterly report showed weaker revenue growth and margin pressure, followed by analyst downgrades, a securities law investigation, and increased insider buying along with a larger share repurchase program. See our latest analysis for Ryan Specialty Holdings. Recent volatility has been sharp, with a 1-day share price return of 3.99% and a 7-day share price return of 12.35%, following a year-to-date share price decline of 31.50%...

Why O-I Glass (OI) is on investors’ radars today O-I Glass (OI) has fallen sharply this year, with the stock down 44.9% year to date and 40.4% over the past 12 months, leaving some investors reassessing the risk and reward trade off. See our latest analysis for O-I Glass. The recent share price recovery, including a 4.8% 7 day share price return after a weaker 90 day share price return of 24.0% and a 1 year total shareholder return decline of 40.4%, points to momentum stabilising from a lower...

Recent performance snapshot and business mix ITT (ITT) has drawn fresh attention after a recent pullback, with the stock down about 11% over the past month and roughly 1% over the past 3 months, despite a 22% total return over the past year. The company, headquartered in Stamford, Connecticut, manufactures engineered components and customized technology solutions for transportation, industrial, and energy markets through three core segments. Motion Technologies generated US$1,479.3m in...

What recent performance says about California Resources (CRC) California Resources (CRC) has drawn investor attention after recent trading, with the stock last closing at US$58.87 and showing mixed short term performance, including a gain of about 0.7% over the past day. See our latest analysis for California Resources. That small 1 day gain comes after a softer patch, with the 7 day share price return down 5.35%, the 30 day share price return down 1.36% and the year to date share price...

In recent weeks, ACV Auctions’ annual meeting reaffirmed its existing board and auditor while management highlighted ongoing macroeconomic pressures, higher Treasury yields, and softer revenue guidance alongside cost structure concerns. The spotlight is now on newer services like ACV MAX and VIPER, which investors see as potential offsets to these headwinds despite the uncertain backdrop. We’ll now examine how softer revenue guidance and macro pressures interplay with ACV Auctions’...

UiPath, Inc. ( NYSE:PATH ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...

We wouldn't blame Western Alliance Bancorporation ( NYSE:WAL ) shareholders if they were a little worried about the...

Pelagos Insurance Capital Limited ( NYSE:PLGO ) stock is about to trade ex-dividend in three days. The ex-dividend date...

We wouldn't blame Butterfly Network, Inc. ( NYSE:BFLY ) shareholders if they were a little worried about the fact that...

In recent days, Haemonetics Corporation saw increased attention as sector-wide interest in medical devices coincided with internal changes, including areshaped reporting segments and updated leadership compensation estimates for President and CEO Christopher A. Simon of US$12,044,701 for 2026. Investors are weighing this mix of sector momentum, perceptions of modest undervaluation, and Haemonetics’ consolidation of its Plasma and Blood Center units into a single Apheresis segment as they...

EOG Resources (EOG) is sharply increasing capital spending in the second half of the year by raising its rig count and ramping coalbed methane drilling in Western Canada, with the goal of higher organic gas volumes. See our latest analysis for EOG Resources. The share price has risen 30.77% year to date to US$140.28, with a 5.23% 1 month share price return and 21.15% 1 year total shareholder return. This suggests momentum has been building as investors weigh the ramp up in spending and...

Ionis Pharmaceuticals (NasdaqGS:IONS) has appointed Ludwig Hantson, Ph.D. to its Board of Directors. Dr. Hantson brings decades of global biopharmaceutical leadership experience from roles at Alexion, Baxter Bioscience/Baxalta, Novartis, and Johnson & Johnson. Ionis Pharmaceuticals focuses on RNA-targeted therapeutics, with several late-stage assets moving closer to potential commercial decisions. As the broader biotech sector continues to emphasize targeted and genetic medicines, the...

Global Ship Lease (GSL) has agreed to acquire 10 new mid size, ultra high reefer, wide beam containerships for about US$917 million, each backed by multi year charters that outline future Adjusted EBITDA expectations. See our latest analysis for Global Ship Lease. At a share price of US$38.13, Global Ship Lease has seen a 9.19% year to date share price return and a 58.32% total shareholder return over one year. This suggests that recent weakness in the 1 month share price is set against...

Recent stock performance snapshot Power Integrations (POWI) has drawn fresh attention after a sharp weekly pullback, with the stock down about 12% over the past week, while still showing a modest gain over the past month and a stronger move in the past 3 months. See our latest analysis for Power Integrations. Despite the sharp 7 day pullback, Power Integrations still has a strong year to date share price return of about 100%. However, the 3 year total shareholder return is down about 16%,...

American Eagle Outfitters, Inc.'s ( NYSE:AEO ) earnings announcement last week was disappointing for investors, despite...

Tyra Biosciences stock reaction Tyra Biosciences (TYRA) has drawn attention after recent trading, with the stock closing at US$25.42 and showing sizeable swings over the past month and past 3 months. This has prompted fresh questions about how investors view this clinical-stage biotech. See our latest analysis for Tyra Biosciences. Recent momentum has cooled, with the share price down 11.4% over the past week and 25.3% over the past month. However, the 1 year total shareholder return of...

This breakdown examines whether Sea at US$82.44 still offers value or whether its story is already reflected in the share price, focusing squarely on what the numbers indicate about the stock. Sea's share price has fallen 7.8% over the past week and is down 37.3% year to date, with a 46.6% decline over the past year, compared with a 29.5% gain over three years. Recent coverage around Sea has highlighted its role as a major Southeast Asian platform business and examined how its different...

Chicagoland expansion puts First Financial Bancorp (FFBC) in focus First Financial Bancorp (FFBC) has finished integrating BankFinancial's systems and rebranding its Chicagoland branches, while also committing US$1 million to local organizations through the First Financial Foundation. This expansion, together with upward earnings estimate revisions and recent stock outperformance over both the month and past 3 months, is drawing fresh attention from investors assessing FFBC's regional growth...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hewlett...

We feel now is a pretty good time to analyse Trulieve Cannabis Corp.'s ( NYSE:TRLV ) business as it appears the company...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Allegion plc...

Mama's Creations, Inc. ( NASDAQ:MAMA ) defied analyst predictions to release its first-quarter results, which were...

Insiders were net buyers of Genasys Inc.'s ( NASDAQ:GNSS ) stock during the past year. That is, insiders bought more...

Some Champion Homes, Inc. ( NYSE:SKY ) shareholders may be a little concerned to see that the Executive Vice President...